Exact Mass: 688.3260683999999
Exact Mass Matches: 688.3260683999999
Found 110 metabolites which its exact mass value is equals to given mass value 688.3260683999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-O-methylbutin-7-O-[(6->1)-3,11-dimethyl-7-hydroxymethylenedodecanyl]-beta-D-glucopyranoside
methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-[(2S,3R)-3-ethyl-2-[(1R)-1-(hydroxymethyl)-2-methoxy-2-oxo-ethyl]-1,2,3,4-tetrahydroindolo[2,3-a]quinolizin-5-ium-7-yl]propanoate|moandaensine
C42H48N4O5 (688.3624517999999)
rel-(4aR,6R,6aR,7S,8S,10R,11aR,12R,12aS,12bR)-5,6,6a,7,8,10,11a,12,12a-decahydro-11a-(1-hydroxy-1-methylethyl)-3,3,6a,9-tetramethyl-1H-azuleno[5,5-f][1,3]benzodioxin-6,7,8,10,12,12b(4aH)-hexol 6,7,12-triacetate 8-benzoate|sumataxin C
furost-25(27)-en-1beta,2beta,3beta,4beta,5beta,7alpha,22,26-octaol-6-one 26-O-beta-D-glucopyranoside
2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate
C32H56O8Sn (688.2996966000001)
Tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene-5,11-diylbis[bis(3,5-dimethylphenyl)phosphine]
N4,N4-Di-1-naphthalenyl-N4,N4-di-2-naphthalenyl-[1,1-biphenyl]-4,4-diamine
4-[(10S,14S,18S)-18-(2-Amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-EN-10-YL]benzylphosphonic acid
Vionactane
C25H46N13O10+3 (688.3490436000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
(R)-1-(threo-4-Hydroxy-L-3,6-diaminohexanoic acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]viomycin
C25H46N13O10+3 (688.3490436000001)
Viomycin(3+)
C25H46N13O10+3 (688.3490436000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
N-[[(3S,9R,10S)-16-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide
(9Z)-17-hydroxyoctadec-9-enoate 17-O-diacetylsophoroside 1,4-lactone
[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)
C28H39F3N8O9 (688.2791960000001)
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia[1].
20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15,16-tetramethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate
3-(1-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione
methyl (2r)-2-[(2s,3r)-7-[(2s)-2-[(2r,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxy-3-oxopropyl]-3-ethyl-1h,2h,3h,4h-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C42H48N4O5 (688.3624517999999)
n-[(3r,4s,7s,10r,15as)-5,8-dihydroxy-7,10-bis(1h-indol-3-ylmethyl)-3-methyl-1,11-dioxo-3h,4h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-c]1-oxa-4,7,10-triazacyclotridecan-4-yl]-2-phenylethanimidic acid
C39H40N6O6 (688.3009180000001)
2-[(2e)-but-2-en-2-yl]-10-[(4s,5s,6s)-4-(dimethylamino)-5-hydroxy-4,6-dimethyloxan-2-yl]-8-[(4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-11-hydroxy-5-methyl-1-oxatetraphene-4,7,12-trione
C39H48N2O9 (688.3359638000001)
(1s,2r,7r,9r,10r,11s,12s,15r,17r,18r)-9,11,18-tris(acetyloxy)-2,15-dihydroxy-17-(2-hydroxypropan-2-yl)-5,5,10,14-tetramethyl-4,6-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁷]octadec-13-en-12-yl benzoate
methyl (1s,2r,5s,12s,15e,24r,25r,26r,28s,40s)-15-ethylidene-34-methoxy-24,30,39-trimethyl-4,6-dioxa-10,17,30,39-tetraazaundecacyclo[26.10.1.1¹⁴,²⁰.0²,²⁶.0⁵,²⁵.0⁷,²³.0⁹,²¹.0¹¹,²⁰.0¹²,¹⁷.0²⁹,³⁷.0³¹,³⁶]tetraconta-7(23),8,10,21,29(37),31,33,35-octaene-40-carboxylate
C42H48N4O5 (688.3624517999999)
(1r,2r,3z,8s,9s,10r,11s,12s,13r,15s,18s,19s)-18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0²,⁹.0¹³,¹⁵.0¹³,¹⁹]henicos-3-en-11-yl (2s)-2-{[(2r)-2-hydroxy-3-methylbutanoyl]oxy}-3-methylbutanoate
methyl (1r,10r,44r,45r)-25-methoxy-4,13-dioxa-17,27,30,40-tetraazatridecacyclo[28.13.1.1¹⁰,¹⁷.0¹,⁵.0⁶,²⁹.0⁸,²⁸.0¹⁰,¹⁴.0²⁰,²⁸.0²¹,²⁶.0³³,⁴¹.0³³,⁴⁴.0³⁴,³⁹.0²⁰,⁴⁵]pentatetraconta-21,23,25,34,36,38,41-heptaene-42-carboxylate
C42H48N4O5 (688.3624517999999)
4',5'-bis(acetyloxy)-3',4-dihydroxy-7-methoxy-2,3',5a,6,6',9',9b-heptamethyl-8,10'-dioxo-2,3a,4,5,9,9a-hexahydro-1h-11'-oxaspiro[cyclopenta[a]naphthalene-3,2'-tricyclo[7.2.1.0¹,⁶]dodecan]-7'-yl acetate
(1s,2s,4s,6r,7s,8r,9s,12s,13s,14s,15s,16s,17s,18r,20s)-6,14,15,16,17,18,20-heptahydroxy-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-19-one
(1'r,2s,3s,3'r,3ar,4r,4'r,5'r,5as,6'r,7's,9'r,9as,9bs)-4',5'-bis(acetyloxy)-3',4-dihydroxy-7-methoxy-2,3',5a,6,6',9',9b-heptamethyl-8,10'-dioxo-2,3a,4,5,9,9a-hexahydro-1h-11'-oxaspiro[cyclopenta[a]naphthalene-3,2'-tricyclo[7.2.1.0¹,⁶]dodecan]-7'-yl acetate
18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0²,⁹.0¹³,¹⁵.0¹³,¹⁹]henicos-3-en-11-yl 2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanoate
(1r,2r,3z,8s,9s,10r,11s,12s,13r,15s,18s,19s)-18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0²,⁹.0¹³,¹⁵.0¹³,¹⁹]henicos-3-en-11-yl 2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanoate
(3r,4r,6s,6ar,7s,8ar,10r,12s,12ar,12br)-3-(1-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione
(1's,2r,2's,4s,4's,5s,7's,8'r,9's,12's,13's,14's,15's,16's,17's,18'r,20'r)-14',15',16',17',18',20'-hexahydroxy-5,7',9',13'-tetramethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one
2-[(2z)-but-2-en-2-yl]-10-[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-4,6-dimethyloxan-2-yl]-8-[(2r,4s,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-11-hydroxy-5-methyl-1-oxatetraphene-4,7,12-trione
C39H48N2O9 (688.3359638000001)
(2s,3s,4s,5r,6r)-6-{[(1s,3as,3bs,5s,5as,7s,9as,11as)-1-[(2s)-2-hydroxy-6-methyl-4-oxoheptan-2-yl]-9a,11a-dimethyl-5-(sulfooxy)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
14,19-dihydroxy-6,16,27,31-tetramethyl-13,20-bis(prop-1-en-2-yl)-8,17,25-trioxaheptacyclo[16.12.1.1⁷,¹⁰.1²³,²⁶.0²,¹⁶.0⁴,⁶.0²⁷,²⁹]tritriaconta-10(33),18(31),23(32)-triene-3,9,15,24,30-pentone
(2r)-n-[(2s)-1-[(1r,9r,10s,11r,12r)-12-(acetyloxy)-1-hydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid
C38H44N2O10 (688.2995804000001)
6,14,15,16,17,18,20-heptahydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-19-one
14',15',16',17',18',20'-hexahydroxy-5,7',9',13'-tetramethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one
(2r)-n-[(2s)-1-[(1r,9r,10r,11s,12s)-12-(acetyloxy)-1-hydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-11-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-10-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid
C38H44N2O10 (688.2995804000001)
(1r,4s)-4-[(4as,6s,8ar)-6-[(2r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-[2-(acetyloxy)propan-2-yl]-2-methyloxolan-2-yl]-4-hydroxypentyl acetate
C34H57BrO9 (688.3185732000001)
9,11,18-tris(acetyloxy)-2,15-dihydroxy-17-(2-hydroxypropan-2-yl)-5,5,10,14-tetramethyl-4,6-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁷]octadec-13-en-12-yl benzoate
n-{1-[12-(acetyloxy)-1-hydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl}-2-hydroxy-2-methylbutanimidic acid
C38H44N2O10 (688.2995804000001)
(3s,4r)-9-[(2s)-3-({2-[(1e,3r,4s)-3,4-dihydroxyhept-1-en-1-yl]-6-methoxyphenyl}methoxy)-2-hydroxy-3-methylbutyl]-4,6-dihydroxy-12-methyl-3-(prop-1-en-2-yl)-3,4-dihydro-2h-1,10-dioxatetraphen-5-one
methyl 2-(3-ethyl-7-{2-[(3e)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxy-3-oxopropyl}-1h,2h,3h,4h-indolo[2,3-a]quinolizin-2-yl)-3-hydroxypropanoate
C42H48N4O5 (688.3624517999999)
(1s,2r,4s,5r,6s,8r,10s,11s,12r,14r,15r,16s,19r,20r,21s)-20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15,16-tetramethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl (2r)-2-methylbutanoate
2-[(2e)-but-2-en-2-yl]-10-[(2r,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-4,6-dimethyloxan-2-yl]-8-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-11-hydroxy-5-methyl-1-oxatetraphene-4,7,12-trione
C39H48N2O9 (688.3359638000001)
n-{1-[12-(acetyloxy)-1-hydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-11-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-10-carbonyl]pyrrolidin-2-yl}-2-hydroxy-2-methylbutanimidic acid
C38H44N2O10 (688.2995804000001)